A diet that produces certain short-chain fatty acids in the gut is shown in lab mice to support the immune system and slow the onset of type 1 diabetes. . . . → Read More: Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes
|
|||||
|
|
 2 comments - (Comments are closed)  New products  Australia, biomedical, chemistry, life sciences, pharmaceuticals, physical sciences, preclinical, university Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth. . . . → Read More: Inhaled Drug Shown Feasible for Postpartum Bleeding Comments are closed Joint ventures/collaborations, New products Australia, biomedical, clinical trials, Europe, life sciences, materials science, pharmaceuticals, physical sciences, U.K., university A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks. . . . → Read More: Low-Dose Multidrug Shown Effective in Hypertension Trial Comments are closed New products, Regulations Australia, biomedical, clinical trials, heart disease, life sciences, pharmaceuticals Plant scientists combined synthetic genetic material with clay nanoparticles, which when sprayed on plants provides enduring protection against viruses. . . . → Read More: RNA-Nanoparticle Spray Protects Against Plant Viruses Comments are closed New products agriculture, Australia, biotechnology, genomics, life sciences, materials science, nanotechnology, physical sciences, U.K., university A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities. . . . → Read More: Trial to Test Drug Combination for Hospital Infections Comments are closed New products, Regulations Australia, biomedical, chemistry, clinical trials, life sciences, pharmaceuticals Researchers devised a treatment for a cancer-related muscle wasting disease using gene transfers that in lab mice block signals promoting muscle degradation. . . . → Read More: Gene Therapy Designed for Muscle Wasting Disease Comments are closed New products Australia, biomedical, biotechnology, cancer, entrepreneurs, genomics, heart disease, life sciences, patent, pharmaceuticals, university Research team members, L-R, Chad Heazlewood, senior author Susan Nilsson, and first author Benjamin Cao (CSIRO) 16 March 2016. A lab in Australia developed a process that makes it easier and faster to harvest blood-forming stem cells for treating diseases such as leukemia. The team led by Susan Nilsson at Monash University in Clayton, . . . → Read More: Technique Speeds, Eases Bone Marrow Stem Cell Collection Comments are closed New products Australia, biomedical, biotechnology, life sciences, medical device, pharmaceuticals, preclinical, stem cells, university Stentrode device (University of Melbourne) 9 February 2016. A team of engineers and medical researchers in Australia show it’s possible to safely implant electrodes in the brain to transmit brain activity with a catheter-delivered stent. A description of the device and delivery process with sheep appears in yesterday’s (8 February) issue of the journal . . . → Read More: Stent Implants Demonstrated to Transmit Brain Activity Comments are closed New products Australia, biomedical, clinical trials, DoD, engineering, entrepreneurs, grant, life sciences, medical device, physical sciences, preclinical, university (National Cancer Institute) 5 February 2016. A company spun-off from Purdue University designed a test that in a recent study detects cases of mesothelioma, a form of lung cancer, several years before symptoms develop. Results of the study conducted by MorNuCo Laboratories in West Lafayette, Indiana appear in the 22 January issue of the . . . → Read More: Test IDs Mesothelioma Years Before Symptoms Appear Comments are closed Regulations Australia, biomarkers, biomedical, cancer, entrepreneurs, life sciences, medical device, university (Mutinka, Pixabay) 19 January 2016. The veterinary medicines company Zoetis is gaining exclusive rights to evaluate and possibly license an alternative to antibiotics in farm animals. While some financial details of the agreement with Anatara Lifesciences in Brisbane, Australia were disclosed, dollar amounts were not revealed. Antibiotics are used to treat disease in livestock . . . → Read More: Zoetis Inks Deal for Antibiotic Alternative in Animals Comments are closed Intellectual property agriculture, Australia, licensing, life sciences, pharmaceuticals |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
